| Ticker Details |
Novo-Nordisk A/S
Novo Nordisk A/S is a healthcare company. It is engaged in the discovery, development, manufacturing and marketing of pharmaceutical products. The company's business segments include, diabetes and obesity care, and biopharmaceuticals.
|
| IPO Date: |
April 1, 1981 |
| Sector: |
Healthcare |
| Industry: |
Pharma |
| Market Cap: |
$166.15B |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.58 | 0.73%
|
| Avg Daily Range (30 D): |
$0.43 | 1.16%
|
| Avg Daily Range (90 D): |
$0.61 | 1.26%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
1.78M |
| Avg Daily Volume (30 D): |
17.34M |
| Avg Daily Volume (90 D): |
19.86M |
| Trade Size |
| Avg Trade Size (Sh.): |
104 |
| Avg Trade Size (Sh.) (30 D): |
130 |
| Avg Trade Size (Sh.) (90 D): |
117 |
| Institutional Trades |
| Total Institutional Trades: |
29,710 |
| Avg Institutional Trade: |
$4.14M |
| Avg Institutional Trade (30 D): |
$2.96M |
| Avg Institutional Trade (90 D): |
$3.34M |
| Avg Institutional Trade Volume: |
.12M |
| Avg Institutional Trades (Per Day): |
7 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.47M |
| Avg Closing Trade (30 D): |
$28.41M |
| Avg Closing Trade (90 D): |
$30.56M |
| Avg Closing Volume: |
122.43K |
|
|
| Splits |
|
Sep 20, 2023
|
2:1
|
|
Jan 09, 2014
|
5:1
|
|
Dec 17, 2007
|
2:1
|
|
Apr 11, 2001
|
5:2
|
|
|
|